Inside the Beltway: Survey hints that industry is largely unaware of EF guidance Sep. 30, 2015 By Mark McCarty No Comments
Inside the Beltway: FDA staff report 'upsurge' in U.S. early feasibility studies Sep. 29, 2015 By Mark McCarty No Comments
New Leader yet to be named: Ubl leaving AdvaMed and med-tech to become new CEO at PhRMA Sep. 28, 2015 By Mark McCarty No Comments
Hawkins sees coverage as biggest entry barrier to med-tech market Sep. 28, 2015 By Mark McCarty No Comments
Inside the Beltway: AdvaMed: IDE benefit-risk draft's use of 'well-designed' term too squishy Sep. 25, 2015 By Mark McCarty No Comments
Inside the Beltway: Burgess lauds CMS for imaging features of 2016 doc fee proposal Sep. 24, 2015 By Mark McCarty No Comments
Execs are in DoJ's crosshairs as FDA revisits off-label issue Sep. 24, 2015 By Mark McCarty No Comments As the off-label promotion issue continues to populate court dockets, the FDA is working on a document that will address the problem.Read More
Inside the Beltway: Device execs in DoJ's crosshairs as FDA revisits off-label issue Sep. 23, 2015 By Mark McCarty No Comments